QCT’s EBT was positively impacted by $53 million and $97 million in the third quarter and first nine months of fiscal 2019, respectively.
In fiscal 2018, all of the costs related to pre-commercial research and development of 5G technologies, of which we recorded $124 million and $340 million in the third quarter and first nine months of fiscal 2018, respectively, were included in unallocated corporate research and development expenses.
 In the first quarter of fiscal 2018, we recorded a charge of $1.2 billion to other expenses related to such EC fine.
Other expenses in the nine months ended June 24, 2018 also included a $1.2 billion charge related to an EC fine (2018 EC fine) (Note 6).
QTL segment results were revised for this correction (Note 7), which resulted in a decrease in QTL revenues and EBT (earnings before income taxes) of $22 million and $95 million for the three and nine months ended June 24, 2018, respectively.
In the second quarter of fiscal 2018, we announced a Cost Plan designed to align our cost structure to our long-term margin targets.QCT’s EBT was positively impacted by $53 million and $97 million in the third quarter and first nine months of fiscal 2019, respectively.
In fiscal 2018, all of the costs related to pre-commercial research and development of 5G technologies, of which we recorded $124 million and $340 million in the third quarter and first nine months of fiscal 2018, respectively, were included in unallocated corporate research and development expenses.
Selling, general and administrative expenses included $50 million and $273 million in the third quarter and first nine months of fiscal 2019, respectively, related to litigation costs.
-$296 million in lower professional fees and costs, primarily driven by Broadcom’s withdrawn takeover proposal in fiscal 2018 and our proposed acquisition of NXP Semiconductors N.V. in fiscal 2018
First nine months 2019 vs. 2018
First nine months 2019 vs. 2018
First nine months 2019 vs. 2018
First nine months 2019 vs. 2018
First nine months 2019 vs. 2018
First nine months 2019 vs. 2018
Revenues in the first six months of fiscal 2019 and the first nine months of fiscal 2018 did not include royalties due on sales of Apple or other products by Apple’s contract manufacturers.
Our research, development and other investments in these new and expanded product areas, industry segments and applications, and related technologies, products and services, as well as in our existing technologies, products and services and new technologies, such as 5G, may not generate operating income or contribute to future results of operations that meet our expectations.